S.2516 - Food and Drug Administration Safety and Innovation Act

An original bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (11)

All Bill Titles

  • Official: An original bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
  • Short: Food and Drug Administration Safety and Innovation Act as introduced.
  • Short: Biosimilar User Fee Act of 2012 as introduced.
  • Short: Generic Drug User Fee Amendments of 2012 as introduced.
  • Short: Medical Device User Fee Amendments of 2012 as introduced.
  • Short: Prescription Drug User Fee Amendments of 2012 as introduced.
  • Short: Food and Drug Administration Safety and Innovation Act as reported to senate.
  • Short: Biosimilar User Fee Act of 2012 as reported to senate.
  • Short: Generic Drug User Fee Amendments of 2012 as reported to senate.
  • Short: Medical Device User Fee Amendments of 2012 as reported to senate.
  • Short: Prescription Drug User Fee Amendments of 2012 as reported to senate.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Latest Actions View All Actions [2]
 
May 07, 2012Placed on Senate Legislative Calendar under General Orders. Calendar No. 389.
May 07, 2012Committee on Health, Education, Labor, and Pensions. Original measure reported to Senate by Senator Harkin. Without written report.

Vote on This Bill

100% Users Support Bill

1 in favor / 0 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC